Immunohematology reagents - naval hospital camp pendleton (nhcp)
Ended Awarded Last action
- Contract number
- HT941025FE034
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $33,474
Award facts
- Contract value 20% obligated
-
- $33,473.88 Current, with exercised options
- $167,369.40 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, MA 01730, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $33,474 | |
| Original award | $0 |
About this award
On October 1, 2025, the Defense Health Agency awarded a delivery order valued at $167,369.40 to Werfen USA LLC for the provision of immunohematology reagents to Naval Hospital Camp Pendleton. The contract, structured as a firm fixed-price delivery order without set-aside designation, is issued under the parent In Vitro Diagnostics, Reagents, and Test GSA Schedule (FSS-65-VII) and extends through September 30, 2030. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, will deliver blood bank testing consumables and related laboratory supplies to support the hospital's immunohematology testing operations.
This delivery order represents one component of Werfen's extensive portfolio of federal contracts with the Defense Health Agency and Veterans Health Administration. The vendor has established itself as a primary supplier of automated diagnostic equipment and reagents across the federal healthcare system, with multiple indefinite delivery vehicle contracts valued in the millions of dollars. The immunohematology reagent delivery order awarded to Naval Hospital Camp Pendleton aligns with Werfen's core business specialization in blood bank analyzer products and blood bank reagent supply, positioning the contractor to provide critical laboratory diagnostic support to the military medical treatment facility over the five-year contract period.
Quick answers
Who was awarded contract HT941025FE034?
HT941025FE034 was awarded to Werfen USA LLC by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract HT941025FE034 worth?
The government has obligated $33,474 on HT941025FE034. Its potential value, with all options, is $167,369.
Is contract HT941025FE034 an order under another contract?
Yes. HT941025FE034 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract HT941025FE034 competed?
The extent of competition for HT941025FE034 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award